EHBP1
Summary: This gene encodes an Eps15 homology domain binding protein. The encoded protein may play a role in endocytic trafficking. A single nucleotide polymorphism in this gene is associated with an aggressive form of prostate cancer. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| EH domain binding protein 1 | MIM:609922 | Ensembl:ENSG00000115504 | HGNC:HGNC:29144 | PA128394620 | 2p15 |
GO terms in EHBP1
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | IEA | GO:0006897 | endocytosis |
| BP | IEA | GO:0015031 | protein transport |
| CC | IEA | GO:0005768 | endosome |
| CC | IDA | GO:0005829 | cytosol |
| CC | IDA | GO:0005886 | plasma membrane |
Gene expression in normal tissue: EHBP1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in EHBP1
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD126 | Tipifarnib | 2 |
| iGMDRD512 | nutlin 3 | 2 |
| iGMDRD560 | MK-2206 | 2 |
| iGMDRD345 | Compound 10b [PMID: 11504634] | 2 |
| iGMDRD494 | Neopeltolide | 5 |
| iGMDRD446 | LY 2183240 | 4 |
| iGMDRD639 | YK 4-279 | 2 |
| iGMDRD237 | ABT-751 | 2 |
| iGMDRD219 | Bax channel blocker | 2 |
| iGMDRD782 | DC-45-A2 | 5 |
| iGMDRD294 | Batimastat | 1 |
| iGMDRD77 | Itraconazole | 6 |
| iGMDRD329 | Merck60 | 1 |
| iGMDRD506 | Fedratinib | 3 |
| iGMDRD366 | PI-103 | 2 |
| iGMDRD780 | PP-30 | 2 |
| iGMDRD562 | Navitoclax | 6 |
| iGMDRD886 | Compound 1541A | 5 |
| iGMDRD60 | Quinoclamine | 4 |
| iGMDRD369 | TGX-115 | 2 |
| iGMDRD64 | Parbendazole | 1 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in EHBP1

